Effect of seminal plasma cholesterol and triacylglycerides concentrations and sperm morphology on semen freezability in domestic cats (Felis silvestris catus).

There is scarce information about the effect of sperm morphology and seminal plasma composition on cat semen freezability. Thus, this study aims to assess the effect of cat sperm morphology and seminal plasma cholesterol (CHOL) and triacylglyceride (TAG) concentrations on sperm post-thaw survival. Ejaculates (n = 49) were evaluated, and seminal plasma was separated and frozen until CHOL and TAG concentrations were measured. The sperm pellet was diluted in a tris-based egg yolk extender, frozen (n = 38), or processed for sperm ultrastructure study (n = 11). Abnormalities recorded were abnormal head shape and size, detached heads, knobbed or ruffled acrosomes, eccentric mid-piece insertion, proximal and distal cytoplasmic droplets, folded and coiled tails, and Dag defect. Ultramicroscopic evaluation detected several sperm abnormalities in fresh semen and some sperm damage in frozen semen. Seminal plasma lipids components were positively correlated with post-thaw motility and acrosome integrity. Higher freezability indices for motility and acrosome integrity were observed in frozen-thawed semen with high seminal plasma CHOL and TAG concentrations. No freezability differences were observed between teratozoospermic and normozoospermic ejaculates. Our results showed that even when seminal plasma was removed before cryopreservation, sperm survival after thawing was significantly higher in samples with high seminal plasma CHOL and TAG concentrations, indicating a rapid adherence to these compounds to the sperm plasma membrane, protecting sperm cells from temperature changes. Nevertheless, there were no differences in sperm freezability by sperm morphology.

Immunocontraception of male domestic cats using GnRH vaccine Improvac.

The domestic cat is a highly prolific species; thus, reproductive control is crucial to reducing feral cat overpopulation. This study aimed to assess the effect of a commercially-available GnRH vaccine for swine on suppressing sperm production in male cats. Twelve sexually mature tomcats were randomly divided into two groups. Treated cats (n = 9) received a GnRH vaccine (Improvac, Zoetis Belgium SA, 0.5 mL sc) twice 4 wk apart, and the control group (CON, n = 3) saline solution (0.5 mL sc). Reproductive parameters and blood samples were recorded every 2 wk, from 6 wk before vaccination until 24 wk after the first dose. Day 0 of the study was defined as the day of primary immunization with either the vaccine or saline solution. Serum testosterone concentrations of treated cats dropped to basal levels 6 wk after D0, while CON cats maintained serum testosterone concentrations between normal ranges during the study period. No differences were observed in pretreatment and CON seminal samples. However, a progressive decrease in seminal quality was observed in treated cats from wk 8 until the end of the study. By wk 24, sperm concentration and total sperm count decreased by 90%, motility decreased by 70%, and viability decreased by 60%. Moreover, testicular volume was reduced by 49%, and penile spines showed almost complete atrophy by the end of the study. Although treated cats showed a decrease in the hematocrit, erythrocyte count, and hemoglobin concentration, values were within the reference range for domestic cats. No differences were observed in the other hematological and biochemical parameters evaluated. Our results agree with previous immunocontraception studies in cats, showing that Improvac vaccination effectively reduced sperm quality, testicular volume, and serum testosterone concentration. Further studies should be carried out to define the Improvac long-term effect.